Endogenous formaldehyde as a potential factor of vulnerability of atherosclerosis: Involvement of semicarbazide-sensitive amine oxidase- mediated methylamine turnover

Atherosclerosis

Volumn 140, Issue 2, 1998, Pages 357-363

  Yu, P H ^a   Deng, Y L ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Acetaldehyde; Amine oxidase; Formaldehyde; Methylamine; Methylglyoxal; SSAO

Indexed keywords

AMINE OXIDASE (COPPER CONTAINING); CARBON 14; FORMALDEHYDE; METHYLAMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DEAMINATION; DISEASE PREDISPOSITION; ENDOTHELIUM INJURY; ENZYME ACTIVITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RISK FACTOR; URINE LEVEL;

ALLYL COMPOUNDS; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; AORTA; ARTERIOSCLEROSIS; BUTYLAMINES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET, ATHEROGENIC; DISEASE SUSCEPTIBILITY; ENZYME INHIBITORS; FORMALDEHYDE; GUANIDINES; KIDNEY; MALE; METHYLAMINES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RISK FACTORS;

EID: 0031758162     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00142-7     Document Type: Article

References (41)

1. Rau L Hypertension, endothelium and cardiovascular risk factors. Am J Med. 90(Suppl 2A):1991;13S-18.
2. Lin SL, Hong CY, Chang MS, Chiang BN, Chien S Long-term nicotine exposure increases aortic endothelial cell and enhances transendothelial macromolecular transport in rats. Atherioscler Thromb. 12:1992;1305-1312.
3. Ross R The pathogenesis of atherosclerosis - an update. New Engl J Med. 314:1986;488-500.
4. Ross R, Glomset JA The pathogenesis of atherosclerosis. New Engl J Med. 295:1976;369-377.
5. Krauss RM. Tangled web of coronary risk factors. Am J Med 1991;90:2A36S-2A41S.
6. Scanu AM, Fless GM Lipoprotein (a): heterogeneity and biological relevance. J Clin Invest. 85:1990;1709-1715.
7. Ward PA Mechanisms of endothelial cell injury. J Lab Clin Med. 118:1991;421-426.
8. Bierman EL Atherogenesis in diabetes. Arterioscler Thromb. 12:1992;647-656.
9. Breslow JL Mouse models of atherosclerosis. Science. 272:1996;685-688.
10. Paigen B, Ishida BY, Verstuyft J, Winters RB, Albee D Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice. Atherosclerosis. 10:1990;316-323.
11. Yu PH, Zuo DM Methylamine, a potential endogenous toxin for vascular tissues: formation of formaldehyde via enzymatic deamination and the cytotoxic effects on endothelial cells. Diabetes. 42:1993;594-603.
12. Yu PH, Zuo DM Formaldehyde produced endogenously via deamination of methylamine; a potential risk factor for initiation of endothelial injury. Atheroscler. 120:1996;189-197.
13. Precious E, Gunn CE, Lyles GA Deamination of methylamine by semicarbazide-sensitive amine oxidase in human umbilical artery and rat aorta. Biochem Pharmacol. 37:1988;707.
14. Yu PH Oxidative deamination of aliphatic amines by rat aorta semicarbazide-sensitive amine oxidase. J Pharm Pharmacol. 42:1990;882.
15. Boor P, Trent MB, Lyles GA, Tao M, Ansari GAS Methylamine metabolism to formaldehyde by vascular semicarbazide-sensitive amine oxidase. Toxicology. 73:1992;251-258.
16. Yu PH Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J Neural Trans. 52:1997;207-222.
17. Wibo M, Duong AT, Godfraind T Subcellular location of semicarbazide-sensitive amine oxidase in rat aorta. Eur J Biochem. 112:1980;87-94.
18. Lewinsohn R Amine oxidase in human blood vessels and non-vascular smooth muscle. J Pharm Pharmacol. 33:1981;569-575.
19. Lyles GA, Singh I Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J Pharm Pharmacol. 37:1985;637-643.
20. Zuo DM, Yu PH Semicarbazide-sensitive amine oxidase and monoamine oxidase in rat brain microvessels, meninges, retina and eye sclera. Brain Res Bull. 33:1993;307-311.
21. Lyles GA, Holt A, Marshal CMS Further studies on the metabolism of methylamine by semicarbazide-sensitive amine oxidase activities in human plasma. J Pharm Pharmacol. 42:1990;322-338.
22. Yu PH, Dyck RF. Impairment of methylamine clearance in uremea patients and its nephropathological implications. Clin Nephrol (in press).
23. Shara MA, Dichkson PH, Bagchi D, Stohs SJ Excretion of formaldehyde, malondialdehyde, acetaldehyde and acetone in the urine of rats in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin, paraquat, endrin and carbon tetrachloride. J Chromatogr B. 576:1992;221-233.
24. Yu PH, Zuo DM Aminoguanidine inhibits semicarbazide-sensitive amine oxidase activity; its implication to advanced glycation and angiopathy in diabetes. Diabetologia. 363:1997;1243-1250.
25. Yu PH, Zuo DM Inhibition of a type B monoamine oxidase inhibitor, (E)-4-Fluoro-β-fluoroethylene benzene butamine (MDL-72974A), on semicarbazide-sensitive amine oxidase isolated from vascular tissues and sera of different species. Biochem Pharmacol. 43:1992;307-312.
26. Yu PH, Lai CT, Zuo DM Formation of formaldehyde from adrenaline in vivo; a potential risk factor endothelial damage. Neurochem Res. 22:1997;615-620.
27. Lyles GA, Chalmers J The metabolism of aminoacetone to methylglyoxal by semicarbazide-sensitive amine oxidase in human umbilical artery. Biochem Pharmacol. 31:1992;1417-1424.
28. Boor PJ, Nelson TJ Allylamine cardiotoxicity: III: protection by semicarbazide and in vivo derangements of monoamine oxidase. Toxicology. 18:1980;87-102.
29. Boor PJ, Hysmith RM Allylamine cardiovascular toxicity. Toxicology. 44:1987;129-144.
30. Lyles GA, Singh I Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta. J Pharm Pharmacol. 37:1985;637-643.
31. Yu PH Deamination of methylamine and angiopathy; toxicity of formaldehyde, oxidative stress and relevance to protein glycoxidation in diabetes. J Neural Trans. 52:1997;207-222.
32. Thornalley PJ The glyoxalase system in health and disease. Mol Aspects Med. 14:1993;287-371.
33. Sipe JD, Carreras I, Gonnerman WA, Cathcart ES, de-Beer MC, de Beer FC Characterization of the inbred CE/J mouse strain as amyloid resistant. Am J Pathol. 143:1993;1480-1485.
34. Nilsson SE, Tryding N, Tufvesson G Serum monoamine oxidase in diabetes mellitus and some other internal diseases. Acta Med Scand. 184:1968;105-108.
35. Tryding N, Nilsson SE, Tufvesson G et al. Physiological and pathological influences on serum monoamine oxidase level. Scand J Clin Lab Invest. 23:1969;79-84.
36. Boomsma F, Derkx FHM, van den Meiracker AH, Veld AJM, Schalekamp MADH Plasma semicarbazide-sensitive amine oxidase activity is elevated in diabetes mellitus and correlates with glycosylated haemoglobin. Clin Sci. 88:1995;675-679.
37. Hayes BE, Clarke DE Semicarbazide-sensitive amine oxidase activity in streptozotocin diabetic rats. Res Comm Chem Pathol Pharmacol. 69:1990;71-83.
38. Elliott J, Fowden AL, Callingham BA, Sharman DF, Silver M Physiological and pathological influences on sheep blood plasma amine oxidase: effect of pregnancy and experimental alloxan-induced diabetes mellitus. Res Vet Sci. 50:1991;334-339.
39. Hayes BE, Ostrow PT, Clarke DE Benzylamine oxidase in normal and atherosclerotic human aortae. Exp Mol Pathol. 38:1983;243-254.
40. Boomsma F, van Veldhuisen DJ, de Kam PJ et al. Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure. Cardiovasc Res. 33:1997;387-391.
41. Baba S, Watanabe Y, Gejyo F, Arakwa M High-performance liquid chromatographic determination of serum aliphatic amines in chronic renal failure. Clin Chim Acta. 136:1984;49-56.